Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Kanako, Hagio"'
Autor:
Kanako Hagio, Kanako C. Hatanaka, Toraji Amano, Yoshihiro Matsuno, Yutaka Hatanaka, Hiroko Yamashita
Publikováno v:
Breast, Vol 60, Iss , Pp 206-213 (2021)
Background: Because a number of years may be required for normal cells to develop into carcinoma, genes involved in tumorigenesis and progression might differ among breast cancers in young women and those in older women. The present study sought to a
Externí odkaz:
https://doaj.org/article/9e974a7c6bb04137a1ebc242de1b9d39
Autor:
Kanako Hagio, Toraji Amano, Hideyuki Hayashi, Takashi Takeshita, Tomohiro Oshino, Junko Kikuchi, Yoshihito Ohhara, Ichiro Yabe, Ichiro Kinoshita, Hiroshi Nishihara, Hiroko Yamashita
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Clinical targeted sequencing allows for the selection of patients expected to have a better treatment response, and reveals mechanisms of resistance to molecular targeted therapies based on actionable gene mutations. We underwent comprehensi
Externí odkaz:
https://doaj.org/article/bcd6587139f6496c8776ae366ad162a1
Autor:
Kanako Hagio-Izaki, Madoka Yasunaga, Masahiro Yamaguchi, Hiroshi Kajiya, Hiromitsu Morita, Masahiro Yoneda, Takao Hirofuji, Jun Ohno
Publikováno v:
BMC Cell Biology, Vol 19, Iss 1, Pp 1-13 (2018)
Abstract Background Interactions of resident bacteria and/or their producing lipopolysaccharide (LPS) with sulcular epithelial keratinocytes may be regulated by autophagy in the gingival sulcus. In this study, we investigated an induction of bacteria
Externí odkaz:
https://doaj.org/article/067564f82443495f96a21d6be70b92af
Autor:
Kanako Hagio, Junko Kikuchi, Kohichi Takada, Hiroki Tanabe, Minako Sugiyama, Yoshihito Ohhara, Toraji Amano, Satoshi Yuki, Yoshito Komatsu, Takahiro Osawa, Kanako C. Hatanaka, Yutaka Hatanaka, Takashi Mitamura, Ichiro Yabe, Yoshihiro Matsuno, Atsushi Manabe, Akihiro Sakurai, Atsushi Ishiguro, Masato Takahashi, Hiroshi Yokouchi, Hirohito Naruse, Yusuke Mizukami, Hirotoshi Dosaka‐Akita, Ichiro Kinoshita
Publikováno v:
Cancer Science.
Autor:
Meiko Nishimura, Takahiro Kogawa, Yuko Akaishi, Misato Ogata, Jun Masuda, Mitsuo Terada, Hitomi Sakai, Kazuki Nozawa, Sasagu Kurozumi, Takamichi Yokoe, Yukinori Ozaki Ozaki, Shu Yazaki, Mai Onishi, Tsutomu Iwasa, Takuma Onoe, Yuta Okumura, Sayaka Nakayama, Kanako Hagio, Yuko Takahashi, Hirokazu Tanino, Junji Tsurutani, Koji Matsumoto, Mototsugu Shimokawa, Toshimi Takano
Publikováno v:
Cancer Research. 82:OT2-19
Background: Abemaciclib is a drug approved for ER-positive and HER2-negative metastatic or recurrent breast cancer and those treatable in an early setting. Some patients with ER-positive and HER2-negative breast cancer pretreated with abemaciclib and
Autor:
Hiroko Yamashita, Kanako C. Hatanaka, Toraji Amano, Yoshihiro Matsuno, Yutaka Hatanaka, Kanako Hagio
Publikováno v:
Breast, Vol 60, Iss, Pp 206-213 (2021)
The Breast : Official Journal of the European Society of Mastology
The Breast : Official Journal of the European Society of Mastology
Background Because a number of years may be required for normal cells to develop into carcinoma, genes involved in tumorigenesis and progression might differ among breast cancers in young women and those in older women. The present study sought to an
Autor:
Manabu Futamura, Yukinori Ozaki, Mai Onishi, Tsutomu Iwasa, Tetsuyo Maeda, Meiko Nishimura, Mototsugu Shimokawa, Mitsuo Terada, Yuko Tsuboguchi, Kazuki Nozawa, Takamichi Yokoe, Jun Masuda, Hirotsugu Isaka, Yuta Okumura, Misato Ogata, Shu Yazaki, Michiko Kurikawa, Hitomi Sakai, Takuma Onoe, Sayuka Nakayama, Akihiko Shimomura, Akihiro Fujimoto, Toshimi Takano, Kanako Hagio, Sasagu Kurozumi
Publikováno v:
Breast Cancer (Tokyo, Japan)
Background Trastuzumab emtansine (T-DM1) treatment for human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer after taxane with trastuzumab and pertuzumab is standard therapy. However, treatment strategies beyond T-DM1 are
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 80:2157-2163
Autor:
Minako Sugiyama, Junko Kikuchi, Yoshihito Ohhara, Kanako Hagio, Toraji Amano, Emi Takakuwa, C. Kanako Hatanaka, Yutaka Hatanaka, Atsushi Manabe, Takeo Sarashina, Masaki Yamamoto, Yusuke Mizukami, Kohichi Takada, Hirohiro Naruse, Takashi Mitamura, Ichiro Yabe, Akihiro Sakurai, Hirotoshi Dosaka-Akita, Ichiro Kinoshita
Publikováno v:
Annals of Oncology. 33:S474
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 47(9)
The characteristic adverse events of olaparib, a PARP inhibitor, are nausea, vomiting, and anemia, and interstitial pneumonia is rarely reported. We report a case of interstitial pneumonia following the treatment of a metastatic breast cancer with ol